文献速递糖尿病

胰岛素剂量调整的糖化血红蛋白在识别C肽定义的部分缓解中表现欠佳:SEARCH for Diabetes in Youth研究

Insulin Dose-Adjusted Hemoglobin A1c Has Suboptimal Performance for Identifying C-Peptide-Defined Partial Remission: The SEARCH for Diabetes in Youth Study.
PubMed 文献 · Diabetes Care · 2026-09-29

该研究分析422名新诊断1型糖尿病青年,以混合餐耐量试验刺激的C肽曲线下面积定义部分缓解,评估IDAA1c≤9的识别效能。结果显示总体灵敏度61%、特异度79%,超重或肥胖者灵敏度仅45%;BMI特异性截断值IDAA1c≤11.6可提高灵敏度至93%但特异度降至54%。

要点

  • IDAA1c≤9识别C肽定义部分缓解的总体灵敏度61%、特异度79%。
  • 超重或肥胖青年中IDAA1c≤9灵敏度仅45%,低估β细胞功能。
  • 超重或肥胖者采用IDAA1c≤11.6可提高灵敏度至93%,但特异度降至54%。

核心结论

  • IDAA1c≤9作为部分缓解筛查试验准确性欠佳,尤其在超重或肥胖青年中低估β细胞功能。
  • BMI特异性截断值可改善灵敏度但降低特异度。

研究设计与样本

  • 分析SEARCH for Diabetes in Youth研究中422名在诊断12个月内完成混合餐耐量试验的参与者数据。
  • 以混合餐耐量试验刺激的C肽曲线下面积均值定义部分缓解。
  • 按BMI百分位(<85th为正常或偏瘦,≥85th为超重或肥胖)分组比较特征。
  • 评估IDAA1c≤9识别部分缓解的灵敏度、特异度及ROC AUC。

主要发现

  • 正常或偏瘦组IDAA1c为8.95,超重或肥胖组为9.28(P=0.043)。
  • 正常或偏瘦组刺激后C肽为1.25 ng/mL,超重或肥胖组为1.88 ng/mL(P<0.001)。
  • 总体IDAA1c≤9预测C肽≥0.91 ng/mL的灵敏度61%、特异度79%、ROC AUC 0.77。
  • 超重或肥胖组IDAA1c≤9灵敏度45%、特异度81%。
  • 超重或肥胖组Youden指数衍生截断值IDAA1c≤11.6的灵敏度93%、特异度54%。

关键数值与推荐

  • IDAA1c计算公式为HbA1c(%)+4×每日胰岛素总剂量(单位/kg/天)。
  • 部分缓解定义基于混合餐耐量试验刺激的C肽曲线下面积均值。
  • 总体IDAA1c≤9预测C肽≥0.91 ng/mL的灵敏度61%、特异度79%、ROC AUC 0.77。
  • 超重或肥胖组IDAA1c≤11.6的灵敏度93%、特异度54%。

临床怎么用

  • 在超重或肥胖1型糖尿病青年中,IDAA1c≤9可能低估部分缓解,需谨慎解读。
  • 可考虑对超重或肥胖青年采用BMI特异性截断值IDAA1c≤11.6以提高筛查灵敏度。
  • IDAA1c作为部分缓解指标在临床和研究中的应用需结合BMI评估。

局限性

  • 研究未在摘要中明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Insulin dose-adjusted hemoglobin A1c (IDAA1c = HbA1c [%] + [4 × total daily dose in units/kg/day]) ≤9 is widely used to define partial remission in pediatric type 1 diabetes and as an eligibility criterion or outcome in disease-modifying therapy trials. However, it has not been validated in U.S. youth. Because higher BMI increases insulin resistance and insulin requirements, we hypothesized that IDAA1c would perform suboptimally in participants with overweight or obesity. RESEARCH DESIGN AND METHODS: We analyzed data from 422 SEARCH for Diabetes in Youth study participants with mixed-meal tolerance test (MMTT)-stimulated C-peptide within 12 months of diagnosis. Partial remission was defined using MMTT-stimulated area under the curve (AUC) mean C-peptide. Participant characteristics were compared by BMI category (<85th percentile [normal or underweight] and ≥85th percentile [overweight or obese]) using Wilcoxon rank sum and Fisher exact tests. Sensitivity, specificity, and receiver operating characteristic (ROC) AUC of IDAA1c ≤9 for identifying partial remission were evaluated. RESULTS: Participants with normal or underweight versus participants with overweight or obesity had lower IDAA1c (8.95 vs. 9.28, P = 0.043) despite lower stimulated C-peptide (1.25 vs. 1.88 ng/mL, P < 0.001). Overall, IDAA1c ≤9 had 61% sensitivity and 79% specificity for predicting C-peptide ≥0.91 ng/mL with an ROC AUC of 0.77. Among participants with overweight or obesity, sensitivity was 45% and specificity 81%. A Youden index-derived cutoff of IDAA1c ≤11.6 improved sensitivity to 93%, with specificity of 54% in participants with overweight or obesity. CONCLUSIONS: IDAA1c ≤9 demonstrated suboptimal accuracy as a screening test for partial remission, especially underestimating β-cell function in youth with overweight or obesity. BMI-specific cutoffs improved sensitivity but reduced specificity.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ferm ML, Huang X, Minard CG, et al. Insulin Dose-Adjusted Hemoglobin A1c Has Suboptimal Performance for Identifying C-Peptide-Defined Partial Remission: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2026. PMID: 42808984. doi:10.2337/dc26-1313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。